NMC Royal Khalifa City: A lifeline for women facing Placenta Accreta Spectrum Disorder

In June 2023, NMC Royal Hospital, Khalifa City, proudly launched its Placenta Accreta Spectrum Disorder (PASD) Program, a groundbreaking initiative offering world-class care for expectant mothers diagnosed with this high-risk condition. Over the past year, 10 women have successfully undergone treatment through this program with each receiving expert, multidisciplinary care tailored to their unique medical needs.

For women diagnosed with PASD, the journey can be overwhelming due to the potential complications involved. The condition, where the placenta embeds too deeply into the uterine wall, poses serious risks during childbirth, often leading to severe bleeding and in many cases, the need for a hysterectomy. This is where the highly specialized PASD team at NMC Royal Hospital, Khalifa City is transforming the standard approach by providing innovative, patient-centred solutions that prioritize both safety and fertility preservation.  

What sets our PASD program apart is our personalized and highly coordinated treatment protocol. Each patient undergoes thorough evaluation, including an MRI confirmation, enabling detailed pre-operative planning and ensuring every expecting mother receives an individualized care plan tailored to her specific condition.  Our multidisciplinary team, which collaborates on every PASD case, includes obstetricians, maternal-fetal medicine specialist, interventional radiologists, urologists, anesthesiologists, intensive care specialists and a highly skilled surgical team.

In many hospitals, a hysterectomy – the surgical removal of the uterus – is often the standard course of action for managing PASD to prevent life-threatening complications. Through our advanced PASD protocols, state-of-the-art facilities and the expertise of our multidisciplinary team, none of the women treated in our PASD program have required a hysterectomy. Furthermore, blood loss was minimal across all cases, resulting in significantly faster recovery and improved long-term maternal health outcomes. This represents a major advancement in PASD treatment, offering women not only hope but also the opportunity to preserve fertility while ensuring the safest possible delivery.

Placenta Accreta Spectrum Disorder (PASD) is one of the most complex pregnancy-related conditions and its management requires expertise, experience and a well-integrated team approach that adapts to each individual case. Early diagnosis and meticulous planning can make all the difference in ensuring safer deliveries and better maternal health outcomes.

At NMC Royal Hospital, Khalifa City, we are committed to leading the way in PASD care, constantly driving innovation to set new benchmarks in women’s health. Our unwavering commitment ensures that every woman facing this condition receives not only the highest level of medical treatment but also the compassion, reassurance and support she deserves.

Our dedication to continuous innovation and excellence in maternal-fetal care ensures that every expecting mother who walks through our doors receives the safest and most effective treatment available today.